Internal Medicine, Pulmonary Disease · San Antonio, TX
NPI
1780681403
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
21 Spurs Ln, Ste 230b
San Antonio, TX, 78240
Phone (210) 690-7400
Groups this clinician bills Medicare through
Medicare paid, 2024
$237K
3,380 services
Medicare patients, 2024
712
Average age 76
Drug cost, 2024
$3.5M
3,133 prescriptions
Company payments, 2025
$3,112
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Randall C Bell was code 99214 (office e&m - established), 716 times for 426 patients. In total Randall C Bell billed 3,380 services in 28 codes, and Medicare paid $237K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-06-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 716 | 426 | $83.29 | $60K |
| 99291 Critical Care E&M | Facility | 561 | 60 | $158.69 | $89K |
| 99232 Hospital E&M - Subsequent | Facility | 457 | 82 | $58.44 | $27K |
| 99231 Hospital E&M - Subsequent | Facility | 413 | 60 | $37.34 | $15K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 328 | 73 | $0.08 | $24.83 |
| 99213 Office E&M - Established | Office | 273 | 234 | $60.07 | $16K |
| 96372 Injection Administration | Office | 114 | 77 | $9.61 | $1,095 |
| 94060 Pulmonary Function Testing | Office | 92 | 92 | $25.46 | $2,342 |
| 94729 Pulmonary Function Testing | Office | 89 | 83 | $39.07 | $3,477 |
| 99204 Office E&M - New | Office | 75 | 75 | $111.59 | $8,369 |
| 94010 Pulmonary Function Testing | Office | 59 | 53 | $19.07 | $1,125 |
| 99233 Hospital E&M - Subsequent | Facility | 56 | 23 | $85.03 | $4,762 |
| 99203 Office E&M - New | Office | 50 | 50 | $78.21 | $3,911 |
| G2012 Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 29 | 25 | $9.21 | $267 |
| 94640 Treatment - Miscellaneous | Office | 14 | 13 | $5.88 | $82.38 |
By year: 2022 $284K for 3,517 services; 2023 $314K for 4,184 services; 2024 $237K for 3,380 services.
Medicare prescription drug claims, 2024
In 2024, the drug Randall C Bell prescribed most often to Medicare patients was Prednisone, with 366 prescriptions and refills. In total Randall C Bell wrote 3,133 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 366 | 684 | 165 | $1,408 |
| Montelukast Sodium Generic | 334 | 826 | 122 | $3,631 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 323 | 522 | 76 | $323K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 279 | 443 | 128 | $13K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 231 | 289 | 72 | $177K |
| Ofev Nintedanib Esylate | 120 | 120 | 20 | $1.6M |
| Symbicort Budesonide/Formoterol Fumarate | 105 | 145 | 24 | $33K |
| Breo Ellipta Fluticasone/Vilanterol | 89 | 151 | 19 | $56K |
| Methylprednisolone Generic | 87 | 96 | 60 | $714 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 86 | 146 | 28 | $14K |
| Spiriva Respimat Tiotropium Bromide | 81 | 151 | 21 | $76K |
| Azithromycin Generic | 77 | 83 | 53 | $416 |
| Pirfenidone Generic | 73 | 89 | 13 | $348K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 64 | 87 | 12 | $36K |
| Clonazepam Generic | 57 | 101 | 20 | $420 |
Brand drugs: 1,506 claims; generic drugs: 1,627 claims; opioid claims: 19.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Randall C Bell $3,112 ($3,112 in general payments such as food, travel and fees) from 20 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $656.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 34 | $656 |
| GlaxoSmithKline, LLC. GSK | 31 | $567 |
| Regeneron Healthcare Solutions, Inc. REGN | 12 | $332 |
| Genzyme Corporation SNY | 16 | $247 |
| Insmed, Inc. INSM | 15 | $219 |
| Viatris Specialty LLC | 9 | $180 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $140 |
| Mallinckrodt Hospital Products Inc. | 6 | $125 |
| Verona Pharma, Inc. VRNA | 5 | $119 |
| United Therapeutics Corporation UTHR | 5 | $117 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.